openPR Logo
Press release

Interleukin Inhibitors Market – Novartis AG; AbbVie; Eli Lilly and Company; Regeneron Pharmaceuticals; Johnson & Johnson Services, AstraZeneca; Bausch Health; GlaxoSmithKline plc

09-04-2019 08:53 AM CET | IT, New Media & Software

Press release from: Data Bridge Market Research

/ PR Agency: Data Bridge Market Research
Interleukin Inhibitors Market types

Interleukin Inhibitors Market types

The Interleukin Inhibitors market research report is an ideal research tool to evaluate the advantages and flaws of the key players together with their competitive analysis. In Interleukin Inhibitors market report, readers get information about comprehensive production and dispatch analysis in point of origin to end user. Furthermore, it will assist you to remain in front of the competitors. The report helps to monitor and examine some developments or changes inside the Interleukin Inhibitors Market. The analysis is full of different demonstrations, and promotes statistics associated with Interleukin Inhibitors market revenue, quantity, CAGR, and reveal, along with regional and global economy predictions. The Interleukin Inhibitors report means to give forefront market knowledge and help leaders take sound venture assessment.

Global Interleukin Inhibitors Market is expected to rise to an estimated value of USD 75.30 billion by 2026, registering a healthy CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the various recent drug approvals and advancements in the development of innovative therapeutic systems for chronic inflammatory disorders.

Interleukin inhibitors are defined as immunosuppressive agents that are used as pharmaceutical components to inhibit the functioning and actions of interleukin. Interleukins are cytokines which function in the immune system regulation, synthesized by lymphocytes, monocytes, macrophages and various other specific cell variants. These inhibitors are finding their applications in treatment of various immunological disorders and inflammatory diseases.


Market Drivers

Increasing awareness amongst the consumers and physicians regarding the benefits amid the availability of these inhibitors can drive the growth of the market
Growth in the initiatives and programs undertaken by various government authorities regarding the promotion in usage of interleukin inhibitors acts as a marker driver
Growing prevalence in the autoimmune disorders and other inflammatory diseases is also expected to drive the growth of the market
Availability of a strong pipeline of products of interleukin inhibitors can also boost the market growth
Segmentation: Global Interleukin Inhibitors Market

By Application

Psoriatic Arthritis
Rheumatoid Arthritis
Inflammatory Bowel Disease
Ankylosing Spondylitis
Systematic Sclerosis
By Type

By Distribution Channel

Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Research Institutes
By Geography

North America
South America
Middle East and Africa

Key Developments in the Market:

In April 2019, AbbVie Inc. announced that they had received US FDA approval for “SKYRIZI™ (risankizumab-rzaa)”, an interleukin inhibitor (IL-23) designed for the treatment of moderate to severe plaque psoriasis for adults that can be subjected to phototherapy or systemic therapy. This approval will help in meeting the advanced treatment requirements of adults for plaque psoriasis, expanding the existing portfolio of immunology therapeutics available with AbbVie Inc
In October 2018, Novartis AG announced that the European Commission had approved their appeal of updating the label of “Cosentyx (secukinumab)” for the treatment of psoriatic arthritis. The drug is designed for inhibiting interleukin-17A (IL-17A). The updated label provides flexibility in dosage up to 300 mg which will exhibit greater choices in therapeutics for patients and physicians
Competitive Analysis:

Global interleukin inhibitors market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of interleukin inhibitors market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major competitors currently working in the global interleukin inhibitors market are Novartis AG; AbbVie Inc.; Eli Lilly and Company; Regeneron Pharmaceuticals; Johnson & Johnson Services, Inc.; AstraZeneca; Bausch Health; GlaxoSmithKline plc; Sun Pharmaceutical Industries Ltd.; Genentech, Inc.; Sanofi and Merck KGaA among others.

Furthermore, the Interleukin Inhibitors market report additionally features market section procedures for different organizations over the globe alongside product examination. The Interleukin Inhibitors report likewise distinguishes and investigations the developing patterns alongside real drivers, difficulties and opportunities in Interleukin Inhibitors market. It has likewise secured and dissected the market and gives insights and data on market size, offers and development factors. Interleukin Inhibitors report has market information and data which can answer a few market issues in various practical territories of promoting, for example, buyers conduct, product, deals, conveyance channel, evaluating, promotion and physical appropriation.



Sopan Gedam

Data Bridge Market Research

Tel: +1-888-387-2818


About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Interleukin Inhibitors Market – Novartis AG; AbbVie; Eli Lilly and Company; Regeneron Pharmaceuticals; Johnson & Johnson Services, AstraZeneca; Bausch Health; GlaxoSmithKline plc here

News-ID: 1829550 • Views: 524

More Releases from Data Bridge Market Research

Elastomer Coated Fabrics Market Analysis, Growth, Share, Trends, and Forecast to …
Market Analysis and Insights: Global Elastomer Coated Fabrics Market Elastomer Coated Fabrics Market is expected to reach USD 14.83 billion by 2027 growing at a rate of 4.34% in the forecast period of 2020 to 2027. Data Bridge Market Research report on global elastomer coated fabrics market analyses the growth of the industries constituting the application areas of these fabrics and provides the market overview of the different segments under this market
Building and Construction Tapes Market 2020 SWOT Analysis & Key Business Strateg …
Market Analysis and Insights: Global Building and Construction Tapes Market Global Building And Construction Tapes Market is expected to reach USD 6.53 billion by 2027 growing at a growth rate of 5.20% in the forecast period 2020 to 2027. The growth of building and construction tapes market is owing to increasing usage of doubles sided tape, duct tape among others in bonding of trims and window attachments. The  Elastomer Coated Fabrics market research report deals
Itaconic Acid Market In-Depth Analysis 2027 – Lead by Itaconix Corporation, Qi …
Market Analysis and Insights: Global Itaconic Acid Market Itaconic Acid Market is expected to reach USD 127.04 million by 2027 growing at a growth rate of 4.20% in the forecast period 2020 to 2027. Increasing usage in agricultural applications and advancement in the bio- based PMMA are the factor for the market growth. Itaconic acid is colorless crystalline carboxylic acid which usually develops naturally. They are usually non-toxic in nature and are biodegradable.
Disposable Spo2 Sensor Market Still Has Grow | Emerging Players Medtronic, Masim …
A disposable SPO2 sensor is a small clip like medical device that monitors the patient blood saturation level. This medical device can attach either on finger, toe and hand. Doctor utilizes these sensors to check how well the patient’s heart is pumping. The SpO2 sensor is used in pulse monitoring for measuring oxygen levels and oxygen saturation level in blood. This sensor can be useful in cases of anaemia, heart attack

All 5 Releases

More Releases for Interleukin

Interleukin Receptor Modulators Therapeutics - Pipeline Analysis 2019
Interleukin receptors are a group of cytokine receptors that are expressed by leukocytes. Interleukin receptors play an important role in the functioning of the immune system. However, with complete knowledge of their role in pathogenesis of different diseases from allergic reactions to autoimmune disorders and even cancer makes these interleukin receptors an attractive target among different available treatment modalities. Download the sample report @ Immune-modulatory role of interleukins as well
Interleukin Market Pharmaceuticals & Healthcare Analysis 2018 to 2025
This report studies the global market size of Interleukin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Interleukin in these regions. This research report categorizes the global Interleukin market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges,
Interleukin-6 (IL-6) Inhibitors Therapeutics Pipeline to Witness Many Collaborat …
The study analyzed that the IL-6 inhibitors therapeutics pipeline comprises approximately 18 active drug candidates in different stages of development. Interleukin-6 inhibitors acts on the IL-6 receptor. IL-6 receptors belong to a group of cytokine receptors that are expressed by leukocytes and plays an important role in the functioning of the immune system. It has a characteristic role in systemic inflammation in numerous disease conditions, including rheumatoid arthritis, and psoriatic
Global and US Interleukin 1 (IL1) Market Size, Trends, Status, Overview and Fore …
An up-to-date research report has been disclosed by Market Research Hub highlighting the title “Global and US Interleukin 1 (IL1) Market Forecast 2025” which provides an outlook of current market growth as well as the expected forecast including Rate on Investment (ROI) together with growing CAGR near XX% during 2018-2025. This report studies the Interleukin 1 (IL1) market status and outlook of global and United States, from angles of players,
Global Interleukin 12 Receptor Market Scope For Healthcare, Latest Trends, Growt …
A fresh report has been added to the wide database of Market Research Hub (MRH) titled “Global Interleukin 12 Receptor Market Research Report (2018-2025)” which provides an outlook of current market value as well as the expected forecast of Rate on Investment (ROI) with growing CAGR of XX% by the end of 2025. The report also studies the Interleukin 12 Receptor market worldwide, especially in North America, China, Europe, Southeast
Asia-Pacific Interleukin Market will Target Emerging Markets by 2022
In this report, the Asia-Pacific Interleukin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Interleukin for these regions, from 2012 to 2022 (forecast), including China Japan South Korea Taiwan India Southeast